Targeting IL-2: an unexpected effect in treating immunological diseases
Regulatory T cells (Treg) play a crucial role in maintaining immune homeostasis since Treg
dysfunction in both animals and humans is associated with multi-organ autoimmune and …
dysfunction in both animals and humans is associated with multi-organ autoimmune and …
IL-2-based approaches to Treg enhancement
F Harris, YA Berdugo, T Tree - Clinical and Experimental …, 2023 - academic.oup.com
Immune homeostasis is heavily dependent on the action of regulatory T cells (Tregs) which
act to suppress the activation of many immune cell types including autoreactive conventional …
act to suppress the activation of many immune cell types including autoreactive conventional …
IL-2 immunotherapy for targeting regulatory T cells in autoimmunity
V Lykhopiy, V Malviya, S Humblet-Baron… - Genes & …, 2023 - nature.com
FOXP3+ regulatory T cells (Treg) are indispensable for immune homoeostasis and for the
prevention of autoimmune diseases. Interleukin-2 (IL-2) signalling is critical in all aspects of …
prevention of autoimmune diseases. Interleukin-2 (IL-2) signalling is critical in all aspects of …
The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases
D Klatzmann, AK Abbas - Nature Reviews Immunology, 2015 - nature.com
Depletion of regulatory T (TReg) cells in otherwise healthy individuals leads to multi-organ
autoimmune disease and inflammation. This indicates that in a normal immune system …
autoimmune disease and inflammation. This indicates that in a normal immune system …
Low-dose IL-2 therapy in autoimmune and rheumatic diseases
H Graßhoff, S Comdühr, LR Monne, A Müller… - Frontiers in …, 2021 - frontiersin.org
Regulatory T cells (Treg) are crucial for the maintenance of peripheral tolerance and for the
control of ongoing inflammation and autoimmunity. The cytokine interleukin-2 (IL-2) is …
control of ongoing inflammation and autoimmunity. The cytokine interleukin-2 (IL-2) is …
Cytokine signaling in the development and homeostasis of regulatory T cells
KH Toomer, TR Malek - Cold Spring Harbor perspectives …, 2018 - cshperspectives.cshlp.org
Cytokine signaling is indispensable for regulatory T-cell (Treg) development in the thymus,
and also influences the homeostasis, phenotypic diversity, and function of Tregs in the …
and also influences the homeostasis, phenotypic diversity, and function of Tregs in the …
Therapeutic potential of interleukin-2 in autoimmune diseases
Y Yuan, AGA Kolios, Y Liu, B Zhang, H Li… - Trends in Molecular …, 2022 - cell.com
Autoimmune diseases are characterized by dysregulation and aberrant activation of cells in
the immune system. Therefore, restoration of the immune balance represents a promising …
the immune system. Therefore, restoration of the immune balance represents a promising …
Interleukin-2 and regulatory T cells in rheumatic diseases
Failure of regulatory T (Treg) cells to properly control immune responses leads invariably to
autoimmunity and organ damage. Decreased numbers or impaired function of Treg cells …
autoimmunity and organ damage. Decreased numbers or impaired function of Treg cells …
Natural and modified IL-2 for the treatment of cancer and autoimmune diseases
M Mizui - Clinical Immunology, 2019 - Elsevier
Abstract Interleukin-2 (IL-2) is a pleiotropic cytokine required for both effector lymphocyte
proliferation/differentiation and regulatory T cell expansion/survival. Ability to receive IL-2 …
proliferation/differentiation and regulatory T cell expansion/survival. Ability to receive IL-2 …
Receptor-gated IL-2 delivery by an anti-human IL-2 antibody activates regulatory T cells in three different species
U Karakus, D Sahin, PRE Mittl, P Mooij… - Science translational …, 2020 - science.org
Stimulation of regulatory T (Treg) cells holds great promise for the treatment of autoimmune,
chronic inflammatory, and certain metabolic diseases. Recent clinical trials with low-dose …
chronic inflammatory, and certain metabolic diseases. Recent clinical trials with low-dose …